Court Opinion

ID: 4677729
Source: CourtListenerOpinion
Date Created: 2021-04-15 20:00:34.216617+00
Date Added: 2024-06-11T08:03:39.996109
License: Public Domain

NOT FOR PUBLICATION                           FILED
                    UNITED STATES COURT OF APPEALS                        APR 15 2021
                                                                      MOLLY C. DWYER, CLERK
                                                                       U.S. COURT OF APPEALS
                           FOR THE NINTH CIRCUIT

JERRY MUTZA, Lead Plaintiff,                    No.    20-55339

                Plaintiff-Appellant,            D.C. No.
                                                8:15-cv-00554-CJC-JCG
 v.

EMULEX CORPORATION; et al.,                     MEMORANDUM*

                Defendants-Appellees.

                   Appeal from the United States District Court
                      for the Central District of California
                   Cormac J. Carney, District Judge, Presiding

                       Argued and Submitted April 7, 2021
                              Pasadena, California

Before: W. FLETCHER, WATFORD, and HURWITZ, Circuit Judges.

      Avago Technologies Wireless Manufacturing, Inc. made a tender offer for all

outstanding stock of Emulex Corporation.        After Emulex’s financial advisor,

Goldman Sachs, opined that the offer was fair, Emulex filed a statement advising

shareholders to tender their shares (the “Recommendation”). The requisite majority

of Emulex shareholders tendered their shares, and the merger was consummated.

      *
             This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
         This putative class action by an Emulex shareholder alleges that Emulex and

its board of directors were negligent and violated §§ 14(e) and 20(a) of the Securities

Exchange Act of 1934 in making the Recommendation.1 The district court dismissed

for failure to state a claim, finding that § 14(e) requires scienter. Varjabedian v.

Emulex Corp., 152 F. Supp. 3d 1226, 1232-34 (C.D. Cal. 2016). We reversed,

finding that § 14(e) can be satisfied by a showing of negligence, and remanded for

the district court to evaluate the complaint under that standard. Varjabedian v.

Emulex Corp., 888 F.3d 399, 408 (9th Cir. 2018).2 On remand, the district court

dismissed the operative amended complaint for failure to state a claim. We affirm.

         1. Section 14(e) “prohibit[s] only misleading and untrue statements, not

statements that are incomplete.” Brody v. Transitional Hosps. Corp., 280 F.3d 997,

1006 (9th Cir. 2002). An omission is therefore actionable only if it “affirmatively

create[s] an impression of a state of affairs that differs in a material way from the

one that actually exists.” Id. The complaint must identify “each statement alleged

to have been misleading” and describe the specific “reason or reasons why the

statement is misleading.” 15 U.S.C. § 78u-4(b)(1).

1
    The complaint also asserted a § 14(d)(4) claim, which is not at issue in this appeal.
2
  The Supreme Court granted certiorari, Emulex Corp. v. Varjabedian, 139 S. Ct.
782 (2019), but later dismissed the writ as improvidently granted, 139 S. Ct. 1407
(2019).

                                             2
      Plaintiff’s § 14(e) claim rests entirely on the failure of the Recommendation

to include a chart, provided by Goldman in connection with its analysis of the tender

offer, that documents premiums over stock price received by shareholders in tender

offers for the stock of other semiconductor companies. The chart shows the

premium offered to Emulex shareholders (about 26% over market value) was within

industry norms but below average. That chart, however, is consistent with the

Recommendation’s summary of Goldman’s analysis; among other things, the

Recommendation included Goldman’s analysis showing that Emulex had below-

average performance. The chart is also consistent with the Recommendation’s

identification of the 26% premium as a reason to support the transaction; the

Recommendation did not compare the premium in the Avago offer to premiums

offered in other transactions or make any claims about the relative value of the

premium to other transactions. Thus, no statements in the Recommendation were

rendered misleading by the omission of the chart. Although perhaps an interested

shareholder would find the chart of interest, its omission from the Recommendation

in this case does not violate § 14(e).

      2. Section 20(a) imposes control person liability, 15 U.S.C. § 78t(a), and

requires proof of an independent securities law violation. See In re NVIDIA Corp.

Sec. Litig., 768 F.3d 1046, 1052 (9th Cir. 2014). Because Plaintiff’s § 14(e) claim

fails, so does his § 20(a) claim.

                                         3
      3. The district court did not abuse its discretion in denying further leave to

amend. Plaintiff identified no additional facts he would have pleaded to remedy the

deficiencies in his operative complaint. See Zucco Partners, LLC v. Digimarc Corp.,

552 F.3d 981, 1007 (9th Cir. 2009).

      AFFIRMED.

                                         4